PAHC — PHIBRO ANIMAL HEALTH CORP
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1069899 ·
Last close
$32.07
Market Cap
$675.67M
52W High
$60.08
52W Low
$28.25
ADV30
326,964
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 383,543,000 | 125,675,000 | 44,653,000 | 24,024,000 | 1,445,118,000 | 54,929,000 | 1,083,291,000 |
| Dec 2025 | 373,910,000 | 132,656,000 | 50,326,000 | 27,459,000 | 1,405,553,000 | 55,486,000 | 1,073,192,000 |
| Sep 2025 | 363,893,000 | 119,783,000 | 51,260,000 | 26,527,000 | 1,385,524,000 | 72,769,000 | 1,073,843,000 |
| Jun 2025 | 378,697,000 | 110,009,000 | 33,718,000 | 17,224,000 | 1,360,900,000 | 68,039,000 | 1,075,218,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$93,080,000
Investing CF
$-63,483,000
Financing CF
$-42,634,000
CapEx
$-45,791,000
Dividends Paid
$-19,457,000
Buybacks
—
EPS Diluted TTM
$2.25
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$316,959,000
Inventory
$517,347,000
Receivables
$215,872,000
ST Investments
$19,022,000
EBIT TTM
$167,579,000
Pretax Income TTM
$126,227,000
Interest Exp TTM
$41,352,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,500,043,008
EBITDA
$234,754,000
Free Cash Flow
$-17,678,250
Enterprise Value
$2,024,026,496
Total Cash
$78,138,000
Total Debt
$788,678,976
Shares Out
21,068,682
Trailing EPS
$2.33
Book Value
$8.92
ROE
30.3%
ROA
8.4%
Div Yield
1.48%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Jun 2025 | 1,296,215,000 | 110,465,000 | 48,264,000 | 1,360,900,000 | 1,075,218,000 | — | 80,124,000 |
| Jun 2024 | 1,017,679,000 | 53,315,000 | 2,416,000 | 982,184,000 | 725,543,000 | — | 87,594,000 |
| Jun 2023 | 977,889,000 | 71,847,000 | 32,606,000 | 971,397,000 | 688,888,000 | — | 13,310,000 |
| Jun 2022 | 942,261,000 | 78,986,000 | 49,175,000 | 931,699,000 | 669,257,000 | — | 31,649,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$3.34
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RLMD | RELMADA THERAPEUTICS, INC. | $672.97M | $6.41 | — |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $666.49M | $8.32 | — |
| CRMD | CorMedix Inc. | $659.00M | $8.40 | — |
| MNPR | Monopar Therapeutics | $714.12M | $106.60 | — |
| STTK | Shattuck Labs, Inc. | $634.17M | $6.64 | — |
News headlines (Yahoo Finance, 1h cache)
PAHC or LZAGY: Which Is the Better Value Stock Right Now?
2026-07-09 15:40 · Yahoo
Phibro Animal Health (PAHC) Leaves Russell Indexes, Is The Stock A Bargain?
2026-07-09 15:10 · Yahoo
Phibro Animal Health (PAHC) Stock Looks Reasonable On Value But Stretched After 138% Gain
2026-07-09 10:12 · Yahoo
Phibro Animal Health (PAHC) Stock Loses Russell Index Spots And Investor Visibility
2026-07-09 06:14 · Yahoo
Can Central Garden's Pet Innovation Fuel Next Growth Phase?
2026-07-06 15:56 · Yahoo
Implied Volatility Surging for Phibro Animal Health Stock Options
2026-07-06 14:09 · Yahoo
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
2026-07-06 13:40 · Yahoo
Q1 Rundown: Phibro Animal Health (NASDAQ:PAHC) Vs Other Branded Pharmaceuticals Stocks
2026-07-01 15:13 · Yahoo
2 Healthcare Stocks for Long-Term Investors and 1 We Turn Down
2026-06-30 12:19 · Yahoo
Wall Street Analysts Predict a 36.23% Upside in Phibro (PAHC): Here's What You Should Know
2026-06-29 13:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.